These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1458968)

  • 1. Optimal low dosage of acetylsalicylic acid (ASA) for the prevention and treatment of ischemic cerebrovascular disease in geriatric patients.
    Ma ZZ; Luo Y; Tang HC; Li CF; Yin ZJ; Li H
    Chin Med J (Engl); 1992 Aug; 105(8):651-6. PubMed ID: 1458968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
    Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
    Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin dose, bleeding time, platelet adhesion and aggregation in cerebral thrombosis.
    Lejeune A; Fattet M; Degos JD
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):237-42. PubMed ID: 3410599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose aspirin and its antithrombotic effect in ischaemic stroke patient.
    Poungvarin N; Ketsa-Ard K
    J Med Assoc Thai; 1989 Aug; 72(8):421-6. PubMed ID: 2809443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ascolong: a new buccal dosage form of acetylsalicylic acid to be used and antiaggregant].
    Kokurina EV; Suslina ZA; Khromov GL; Davydo AB; Metelitsa VI; Ionova VG; Tanashian MM; Demina EG; Bochkareva EV; Belolipetskaia VG; Deev AD; Kucheriaeva NG; Zidra SI; Gorin NN; Rumiantsev DO
    Ter Arkh; 1998; 70(1):32-7. PubMed ID: 9532649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
    Davì G; Catalano I; Spatola A; Alaimo P; Notarbartolo A; Cerbone AM; Strano A
    Cardiologia; 1989 Jan; 34(1):69-71. PubMed ID: 2720715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acetylsalicylic acid in the treatment of cardiovascular and cerebrovascular diseases].
    Landmark K
    Tidsskr Nor Laegeforen; 1997 Dec; 117(30):4432-6. PubMed ID: 9456592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basis for aspirin dosage in stroke prevention.
    Brandon RA; Eadie MJ
    Clin Exp Neurol; 1987; 23():47-54. PubMed ID: 3665179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolongation and normalization of bleeding time during therapy with different doses of acetylsalicylic acid].
    Epp K; Nolte H
    Anaesthesist; 1993 May; 42(5):300-4. PubMed ID: 8317687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheological background of acetylsalicylic acid resistance.
    Feher G; Koltai K; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low dose acetylsalicylic acid in secondary prevention of stroke].
    Deecke L; Zeiler K
    Wien Klin Wochenschr; 1993; 105(17):485-7. PubMed ID: 8212707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low- versus high-dose aspirin in prevention of ischemic stroke.
    Adams HP; Bendixen BH
    Clin Neuropharmacol; 1993 Dec; 16(6):485-500. PubMed ID: 9377584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of aspirin resistance in persons with previous ischemic stroke.
    Helgason CM; Bolin KM; Hoff JA; Winkler SR; Mangat A; Tortorice KL; Brace LD
    Stroke; 1994 Dec; 25(12):2331-6. PubMed ID: 7974569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
    Gao BT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):148-51, 191. PubMed ID: 2591268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.